India Pharma Inc

Rediff.com » News » India Pharma Inc

News for India Pharma Inc

News
Business

India probes eye drop linked to vision loss in US

A day after its plant was inspected by Indian drug regulatory bodies over allegations that its eye drop was linked to vision loss in the United States, Tamil Nadu-based Global Pharma Healthcare has......

Govt approves 2 new vaccines, Covid drug for emergency use

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drugs Standard Control Organisation (CDSCO) has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological......

Serum's Covid vaccine, Covovax, recommended for approval

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's COVID-19 vaccine 'Covovax' with certain conditions,......

Twitter deliberately chose path of non-compliance: Prasad

IT minister Ravi Shankar Prasad on Wednesday slammed Twitter for deliberate defiance and failure to comply with the country's new IT rules, which has led to the United States giant losing its......

Twitter deliberately chose path of non-compliance: Prasad

Information and Technology Minister Ravi Shankar Prasad on Wednesday said Twitter failed to comply with intermediary guidelines and has "deliberately" chosen the path of non-compliance despite......

India Inc capital expenditure story gets cement to semiconductor push

Corporate India is starting to step up its capital expenditure plans amid government incentives and signs of rising demand, company executives and analysts have indicated. Illustration: Uttam......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

Corporate earnings growth to drive the next leg of market rally: Analysts

The Indian markets have seen a good run in the last three months with the S&P BSE Sensex rising around 7 per cent and the Nifty50 moving up 7.5 per cent. Illustration: Dominic Xavier/Rediff.com......

Shift to new norms may hamper growth, margins for Cummins India in FY24

Over the past three trading sessions, the stock of Cummins India has gained about nine per cent on strong January-March quarter (Q4) results and good near-term prospects. Its Q4 performance was led......

Wipro chairman Rishad Premji's compensation down 50% as profits fall

Rishad Premji, chairman of IT services major Wipro, saw his compensation for FY23 decline by almost 50 per cent year-on-year, due to a fall in the firm’s profit. Photograph: PTI Photo......

Rediff News

India Pharma Inc

News for India Pharma Inc

India probes eye drop linked to vision loss in US

Govt approves 2 new vaccines, Covid drug for emergency use

Serum's Covid vaccine, Covovax, recommended for approval

Twitter deliberately chose path of non-compliance: Prasad

Twitter deliberately chose path of non-compliance: Prasad

India Inc capital expenditure story gets cement to semiconductor push

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Corporate earnings growth to drive the next leg of market rally: Analysts

Shift to new norms may hamper growth, margins for Cummins India in FY24

Wipro chairman Rishad Premji's compensation down 50% as profits fall

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS